Amedisys, Inc. ( AMED) - Key Metrics
Stock symbol AMED is outdated, potentially delisted? Maybe it is available on other exchange?
AMED Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q2 | $18.93 | $2.06 | $2.05 | $2.02 |
| 2025Q1 | $18.14 | $1.86 | -$0.11 | -$0.15 |
| 2024Q4 | $18.28 | -$0.62 | $2.15 | $2.11 |
| 2024Q3 | $17.95 | $1.27 | $3.23 | $3.18 |
| 2024Q2 | $18.08 | $0.99 | $1.60 | $1.55 |
AMED Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q2 | ? | 11.95 |
| 2025Q1 | ? | 12.45 |
| 2024Q4 | ? | -36.44 |
| 2024Q3 | ? | 19.06 |
| 2024Q2 | ? | 24.47 |
AMED Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2025Q2 | 2.06% | ? |
| 2025Q1 | -0.16% | ? |
| 2024Q4 | 2.33% | ? |
| 2024Q3 | 3.30% | ? |
| 2024Q2 | 1.60% | ? |
AMED
Price: $100.99
52 week price:
Payout Ratio Range:
Earnings Per Share: 2.57 USD
P/E Ratio: 38.33
Exchange: NMS
Sector: Healthcare
Industry: Medical Care Facilities
Country: United States
Volume: 187889
Ebitda: 29.5 millionMarket Capitalization: 3.2 billion